Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Alcohol Drinking 11Pancreatic Neoplasms 6Neoplasms 5Smoking Cessation 4Pancreatic Cyst 4Cancer Pain 4Agnosia 4Smoking 3Pain 3Depression 3Prostatic Neoplasms 2Postoperative Complications 2Neoplasms, Cystic, Mucinous, and Serous 2Multiple Endocrine Neoplasia Type 1 2Lymphoma, Follicular 2Lymphoma 2Leukemia 2Infections 2Gliosarcoma 2Glioblastoma 2Condylomata Acuminata 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Cardiovascular Diseases 2Breast Neoplasms 2Brain Neoplasms 2Alcoholism 2Wounds and Injuries 1Warts 1Waldenstrom Macroglobulinemia 1

Interventions

pembrolizumab 156Gemcitabine 139Capecitabine 121Paclitaxel 119Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 93Cisplatin 90Irinotecan 88Carboplatin 85Radiosurgery 83Cyclophosphamide 71Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Ethanol × Clear all
NCT00009854 2013-11-06

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

National Cancer Institute (NCI)

Phase 1/2 Unknown
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡